LAROTRECTINIB
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | LAROTRECTINIB |
| DrugBank ID | DB14723 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 9 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| acute lymphoblastic/lymphocytic leukemia | TxGNN Knowledge Graph | L5 |
| gastrointestinal stromal tumor | TxGNN Knowledge Graph | L5 |
| richter syndrome | TxGNN Knowledge Graph | L5 |
| follicular lymphoma | TxGNN Knowledge Graph | L5 |
| neoplasm of mature b-cells | TxGNN Knowledge Graph | L5 |
| chronic lymphocytic leukemia/small lymphocytic lymphoma | TxGNN Knowledge Graph | L5 |
| cystic fibrosis | TxGNN Knowledge Graph | L5 |
| rheumatoid arthritis | TxGNN Knowledge Graph | L5 |
| metastatic melanoma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11